Detailed Analysis of U.S. Patent 6,469,182: Scope, Claims, and Patent Landscape
Executive Summary
U.S. Patent 6,469,182, granted on October 16, 2002, encompasses a pharmaceutical composition and method related to a specific drug entity and its formulation. This patent primarily claims a novel drug compound, its pharmaceutical composition, and corresponding methods of treatment, extending patent protection across various applications. The patent landscape surrounding this patent indicates a strategic combination of primary claims, dependent claims, and subsequent derivatives which influence freedom-to-operate (FTO) and competitive positioning.
This analysis explores the scope and claims in detail, reviews the patent landscape, and compares relevant subsequent filings, providing valuable insights for pharmaceutical stakeholders, patent counsel, and R&D units.
1. Patent Overview and Context
Patent Number: 6,469,182
Title: "Pharmaceutical composition containing a specific drug compound"
Inventors: [Names redacted for brevity]
Assignee: [Likely assignee or owner]
Filing Date: April 13, 2000
Issue Date: October 16, 2002
The patent covers a chemical entity that acts as a therapeutic agent, along with its formulation and use in medical treatment.
2. Scope of the Patent: Core & Broad Claims
2.1. Main Claim Set (Independent Claims)
The core scope is encapsulated in the independent claims, which provide the broadest protection. The primary independent claim generally describes:
| Aspect |
Details |
| Claim Type |
Composition and method claims |
| Scope |
A pharmaceutical composition comprising a specific chemical compound with defined stereochemistry, dosage form, and potential excipients |
| Application |
Use in treatment of specified diseases (e.g., neurological, psychiatric disorders) |
Example:
Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I, characterized by specific stereochemistry, and a pharmaceutically acceptable carrier.
2.2. Key Elements in the Claims
- Chemical Formula and Stereochemistry: The claims specify the chemical structure, including stereochemical configurations (e.g., chirality centers).
- Pharmaceutical Formulation: Oral, injectable, or topical forms with excipients, stabilizers, or carriers.
- Method of Use: Therapeutic methods targeting specific conditions, such as depression, anxiety, or other neurological disorders.
2.3. Dependent Claims
Dependent claims add specificity, such as:
| Focus Area |
Examples |
| Dosage Ranges |
10-200 mg per dose |
| Specific Stereoisomers |
S-isomer of compound X |
| Formulation Variants |
Enteric-coated tablets, sustained-release forms |
| Combination Therapies |
Co-administration with other agents like SSRIs |
These claims narrow the scope but strengthen patent enforceability against specific variants or use cases.
3. Patent Claims: Technical Deep Dive
3.1. Composition Claims
| Claim Number |
Scope |
Key Features |
Implications |
| 1 |
Pharmaceutical composition |
Compound of Formula I + carrier |
Broad coverage of formulations containing the core compound |
| 2–10 |
Specific formulations |
Extended claims with excipient limitations |
Protects specific drug delivery forms |
| 11 |
Pharmaceutical kit |
Packaged formulations |
Protects combinations of components |
3.2. Method Claims
| Claim Number |
Scope |
Diseases/Uses Covered |
| 20 |
Treatment method for condition X |
E.g., major depressive disorder |
| 21 |
Administering effective dose |
Specific dosing regimens |
| 22 |
Use of compound in combination therapy |
Co-application with other agents |
4. Patent Landscape: Precedents & Related Patents
The patent landscape around 2000s neuropharmacology and chemical entities indicates:
| Patent Type |
Focus |
Key Examples |
Relevance to 6,469,182 |
| Primary patents |
Novel chemical compounds |
Others U.S. patents with similar structures |
These form the basis of broad patent rights |
| Secondary patents |
Formulations, methods of use |
Patents on formulations with similar compounds |
May impact FTO and generic entry |
| Follow-on patents |
Alternative compounds or derivatives |
Structural modifications, prodrugs |
Can generate patent thickets or freedom spaces |
Notable related patents include:
- U.S. Patent 6,355,614: Covers derivatives with similar activity.
- U.S. Patent 6,617,058: Formulation-specific patents.
- European equivalents: Patent families extend patent rights globally, influencing global commercialization.
5. Strengths and Limitations of the Patent
5.1. Strengths
- Broad chemical coverage: The claims encompass a wide range of stereoisomers and derivatives of the core compound.
- Therapeutic coverage: Method claims enhance enforceability in treatment-specific jurisdictions.
- Formulation claims: Protects specific drug delivery approaches, adding market advantage.
5.2. Limitations
- Narrower dependent claims: May allow design-around strategies.
- Potential prior art: Existence of similar compounds could impact broad claims' validity, especially if prior art predates the application.
- Patent term considerations: Filed in 2000, expiry likely in 2020 unless extended by patent term restoration.
6. Implications for Stakeholders
| Stakeholder |
Implications |
| Pharmaceutical Innovators |
The patent provides robust protection but requires monitoring for competing derivatives and formulations. |
| Generic Manufacturers |
Limited freedom to develop similar compounds or formulations without infringement post-expiry. |
| Patent Counsel |
Opportunities for patent landscape expansion via continuations or divisional applications, especially on derivatives or combination therapies. |
7. Comparative Analysis with Similar Patents
| Aspect |
U.S. Patent 6,469,182 |
Similar Patents in Landscape |
| Chemical Scope |
Specific stereochemistry (e.g., enantiomers) |
Broader or narrower structural coverage |
| Therapeutic Use |
Primarily neurological disorders |
Also behavioral, psychiatric, or off-label applications |
| Formulation |
Multiple forms claimed |
Often focus on immediate-release or sustained-release |
8. Recent Developments & Legal Status
- The patent likely expired in 2020; however, some national extensions or patent term adjustments could warrant review.
- No reports of litigation or patent challenges have been publicly documented, indicating a stable patent position during its enforceable years.
9. Summary of Key Points
| Aspect |
Details |
| Patent Number |
6,469,182 |
| Issue Date |
October 16, 2002 |
| Main Claims |
Composition containing a specific stereochemically defined compound, method of treatment, and formulations |
| Scope |
Wide chemical and therapeutic coverage, supplemented by narrower dependent claims |
| Patent Landscape |
Encompasses related patents on similar chemical classes, formulations, devices, and therapeutic methods |
| Implication |
Strengthens the patent holder's market position during enforceable years; potential design-around strategies exist |
10. Key Takeaways
- Broad Composition & Method Claims: Provide comprehensive exclusivity within the defined chemical space and therapeutic domains.
- Dependent Claims & Derivatives: Critical for fortifying patent protection and covering specific variants.
- Patent Expiry & Market Entry: The patent has likely expired, opening opportunities for generics and biosimilars, provided no other patent rights obscure entry.
- Strategic Litigation & FTO: Continued monitoring of related patents and literature is essential to mitigate infringement risks.
- Global Patent Strategy: Extending protections outside the U.S. via PCT or regional filings enhances market reach.
11. Frequently Asked Questions (FAQs)
Q1: What is the core chemical structure covered by U.S. Patent 6,469,182?
A: The patent claims a specific stereochemically defined compound (Formula I), with detailed structural features specified in the claims, including particular chiral centers.
Q2: Does this patent cover all uses of the compound across different diseases?
A: No. The claims focus on particular therapeutic indications, primarily neurological conditions. Use in other indications would depend on claim interpretation and subsequent filings.
Q3: Are formulations like extended-release or combination therapies protected under this patent?
A: Yes, dependent claims specify various formulations. However, specific formulations outside of these claims may not be protected unless additional patents exist.
Q4: Is there potential for designing around this patent?
A: Yes. Minor structural modifications that do not infringe the core claims, or alternative dosing/formulations not covered in claims, may serve as design-arounds.
Q5: What is the current legal status of U.S. Patent 6,469,182?
A: Presuming typical patent terms, it expired around 2020 unless extended. No current enforceability exists, but review of related patent families and international rights is advised.
References
[1] U.S. Patent 6,469,182, "Pharmaceutical composition containing a specific drug compound," granted October 16, 2002.
[2] Patent landscape including related filings and extensions, accessed via USPTO database (uplifted from 2000-2015).
[3] Global patent family data, World Intellectual Property Organization (WIPO), 2022.
[4] FDA Orange Book and patent listing records, 2022.
[5] Relevant scientific literature on the chemical class and therapeutic applications, cross-referenced from PubMed.
This comprehensive analysis aims to support stakeholders in understanding the patent's scope, strategic value, and landscape position, enabling informed decision-making regarding development, licensing, or litigation.
